Revenue $2.98B, up 5.0% on a year earlier. Healthcare Systems & Technologies Sales $806.00M, up 4.3%. Diluted EPS $0.57 against -$0.09.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.98B | $2.96B | $2.83B | +5.0% |
| Operating income | $225.00M | $217.00M | $172.00M | +30.8% |
| Net income | $294.00M | $126.00M | -$46.00M | |
| Diluted EPS | $0.57 | $0.24 | -$0.09 | |
| Operating cash flow | $558.00M | $285.00M | $237.00M | +135.4% |
| Dividend per share | $0.01 | $0.01 | $0.17 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Healthcare Systems & Technologies Sales | $806.00M | $773.00M | +4.3% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Baxter International (BAX) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/BAX/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
